Evidence map›Paper›PMID 22375065›Full record

ArticleJournal of cell science2012

Multiple post-translational modifications regulate E-cadherin transport during apoptosis.

Fei Geng, Weijia Zhu, Richard A Anderson, Brian Leber, David W Andrews

Abstract read
In one paragraph

Article in Journal of cell science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. The IRE1Cell stress · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Cells · 2023
    Review
  7. Article
  8. Article
  9. IRF6 Regulates the Delivery of E-Cadherin to the Plasma Membrane.The Journal of investigative dermatology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer.Frontiers in cell and developmental biology · 2020
    Article
  16. International journal of molecular sciences · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. The Many Ways by WhichMolecules (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fei GengDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Weijia Zhu
Richard A Anderson
Brian Leber
David W Andrews
McMaster University · CAUniversity of Wisconsin–Madison · US

Funding

Targeting of Phosphoinositide Signaling in Migration, Invasion and MetastasisR01GM057549 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 1998 to 2019
$5.7M
PI Signaling Role in Epithelial/Mesenchymal TransitionR01CA104708 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 2004 to 2014
$2.9M
CIHR FRN 10490NCI NIH HHS R01 CA104708NIGMS NIH HHS R01 GM057549
6 · The paper itself

Abstract

E-cadherin is synthesized as a precursor and then undergoes cleavage by proprotein convertases. This processing is essential for E-cadherin maturation and cell adhesion. Loss of cell adhesion causes detachment-induced apoptosis, which is called anoikis. Anoikis can be inhibited despite loss of cell-matrix interactions by preserving E-cadherin-mediated cell-cell adhesion. Conversely, acute loss of E-cadherin sensitizes cells to apoptosis by unknown post-translational mechanisms. After treatment of breast cancer cells with drugs, we found that two independent modifications of E-cadherin inhibit its cell surface transport. First, O-linked β-N-acetylglucosamine (O-GlcNAc) modification of the cytoplasmic domain retains E-cadherin in the endoplasmic reticulum. Second, incomplete processing by proprotein convertases arrests E-cadherin transport late in the secretory pathway. We demonstrated these E-cadherin modifications (detected by specific lectins and antibodies) do not affect binding to α-catenin, β-catenin or γ-catenin. However, binding of E-cadherin to Type I gamma phosphatidylinositol phosphate kinase (PIPKIγ), a protein required for recruitment of E-cadherin to adhesion sites, was blocked by O-GlcNAc glycosylation (O-GlcNAcylation). Consequently, E-cadherin trafficking to the plasma membrane was inhibited. However, deletion mutants that cannot be O-GlcNAcylated continued to bind PIPKIγ, trafficked to the cell surface and delayed apoptosis, confirming the biological significance of the modifications and PIPKIγ binding. Thus, O-GlyNAcylation of E-cadherin accelerates apoptosis. Furthermore, cell-stress-induced inactivation of proprotein convertases, inhibited E-cadherin maturation, further exacerbating apoptosis. The modifications of E-cadherin by O-GlcNAcylation and lack of pro-region processing represent novel mechanisms for rapid regulation of cell surface transport of E-cadherin in response to intoxication.

Indexed as

ApoptosisProtein Processing, Post-TranslationalAcetylglucosamineAnimalsAntigens, CDCadherinsCell MembraneDogsEndoplasmic ReticulumGlycosylationHEK293 CellsHumansMadin Darby Canine Kidney CellsMCF-7 CellsModels, BiologicalPeptides1-phosphatidylinositol-4-phosphate 5-kinaseAcetylglucosamineAntigens, CDCadherinsCDH1 protein, humanPeptidesPhosphotransferases (Alcohol Group Acceptor)polyserineThapsigargin

Identifiers

PMID22375065
PMCPMC3706076
OpenAlexW2164268350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.